Thank you to everyone who took the time to share their thoughts and experiences regarding access to ovarian cancer drug treatments. We have submitted our response to the Scottish Medicines Consortium and used what you told us throughout. We wil share further information as it becomes available.
Niraparib is a new cancer drug currently being assessed to see if it can be made available to women through the NHS.
Target Ovarian Cancer has been invited to represent the views of women living with ovarian cancer in Scotland.
There is a separate process taking place in England where the National Institute for Health and Care Excellence (NICE) is deciding whether niraparib should be made available on the NHS. Northern Ireland and Wales will then also decide on whether to fund niraparib based on the decision made by NICE.